Stellus Capital Investment Corporation (SCM)
SCM trades on NYSE in Finance, Finance/Investors Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:InterestAndDividendIncomeOperating), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1551901/000110465926026432/0001104659-26-026432-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | SCM on NYSE |
| Sector | Finance |
| Industry | Finance/Investors Services |
| Country | United States |
| IPO year | 2012 |
| SEC CIK | 0001551901 |
| Incorporated in | MD |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $97.8M |
| Net income | $27.0M |
| Operating income | Not in SEC XBRL data |
| Net margin | 27.7% |
| Operating margin | Operating income not reported |
| Revenue growth | -2.1% |
| Cash | $25.1M |
| Total assets | $1.0B |
| P/E (computed) | 6.9× |
| P/S (computed) | 1.9× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-09 |
| Cash and burn | $2.3M cash; operating cash flow $16.5M a quarter. | Report 2026-09-30 |
| Shares outstanding | 28,179,374 (2026-11-09); 28,947,254 a year earlier; 24,125,642 three years earlier. | Cover page 2026-11-09 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Deloitte & Touche LLP, Houston, Texas, United States | PCAOB Form AP 2026-03-25 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $871K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $21.2M | -$6.4M | $957K | $2.3M | $123.0M | $89.0M | 10-Q 2026-11-09 |
| Q2 2026 2026-06-30 | $21.6M | $16.2M | $33.4M | $5.1M | $122.9M | $92.8M | 10-Q 2026-08-10 |
| Q1 2026 2026-03-31 | $22.3M | $1.7M | $22.8M | $3.4M | $122.8M | $95.9M | 10-Q 2026-05-11 |
| Q4 2025 2025-12-31 | $24.0M | $5.2M | $9.0M | $25.1M | $122.7M | $97.8M | 10-K 2026-03-11 |
| Q3 2025 2025-09-30 | $25.0M | $6.7M | -$20.2M | $9.0M | $172.5M | $98.1M | 10-Q 2026-11-09 |
| Q2 2025 2025-06-30 | $24.7M | $10.1M | $23.7M | $40.0M | $172.3M | $98.5M | 10-Q 2026-08-10 |
| Q1 2025 2025-03-31 | $24.1M | $5.0M | -$36.9M | $10.9M | $99.6M | $99.0M | 10-Q 2026-05-11 |
| Q4 2024 2024-12-31 | $24.3M | $8.7M | -$31.8M | $20.1M | $99.4M | $99.9M | 10-K 2026-03-11 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B2 | 2025-09-23 |
| Latest annual report | 10-K | 2026-03-11 |
| Latest quarterly / interim | 10-Q | 2026-11-09 |
| Latest current report FORM 8-K | 8-K | 2026-07-29 |
| Latest proxy | DEFA14A | 2026-05-04 |
Source: SEC EDGAR submissions feed, 445 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -7.2% |
| 1 month | -5.1% |
| 3 months | -24.2% |
| Year to date | -46.8% |
| 1 year | -43.7% |
| From 52-week high | -49.8% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Finance/Investors Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GRX | The Gabelli Healthcare & Wellness Trust Common Shares of Beneficial Interest | $10.58 | +1.63% | $180.8M |
| FTF | Franklin Limited Duration Income Trust Common Shares of Beneficial Interest | $5.33 | -1.11% | $215.4M |
| ACV | Virtus Diversified Income & Convertible Fund Common Shares of Beneficial Interest | $22.50 | -1.75% | $233.2M |
| GNT | GAMCO Natural Resources Gold & Income Trust | $8.07 | -4.83% | $149.1M |
| RFMZ | RiverNorth Flexible Municipal Income Fund II Inc. | $11.65 | +0.09% | $283.7M |
| FINS | Angel Oak Financial Strategies Income Term Trust Common Shares of Beneficial Interest | $11.69 | +0.99% | $293.0M |
| CION | CION Investment Corporation | $5.99 | -1.64% | $294.7M |
| GLU | Gabelli Global Utility Common Shares of Beneficial Ownership | $18.42 | -1.94% | $109.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier